These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 30125244)

  • 21. Widespread decreases in cortical muscarinic receptors in a subset of people with schizophrenia.
    Gibbons AS; Scarr E; Boer S; Money T; Jeon WJ; Felder C; Dean B
    Int J Neuropsychopharmacol; 2013 Feb; 16(1):37-46. PubMed ID: 22338582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of muscarinic m1 receptor genetic polymorphisms with psychiatric symptoms and cognitive function in schizophrenic patients.
    Liao DL; Hong CJ; Chen HM; Chen YE; Lee SM; Chang CY; Chen H; Tsai SJ
    Neuropsychobiology; 2003; 48(2):72-6. PubMed ID: 14504414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The mediodorsal thalamic nucleus and schizophrenia.
    Alelú-Paz R; Giménez-Amaya JM
    J Psychiatry Neurosci; 2008 Nov; 33(6):489-98. PubMed ID: 18982171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disinhibition of the mediodorsal thalamus induces fos-like immunoreactivity in both pyramidal and GABA-containing neurons in the medial prefrontal cortex of rats, but does not affect prefrontal extracellular GABA levels.
    Bubser M; de Brabander JM; Timmerman W; Feenstra MG; Erdtsieck-Ernste EB; Rinkens A; van Uum JF; Westerink BH
    Synapse; 1998 Oct; 30(2):156-65. PubMed ID: 9723785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic disconnection between the mediodorsal nucleus of the thalamus and cortical Brodmann's areas of the left hemisphere in schizophrenia.
    Mitelman SA; Byne W; Kemether EM; Hazlett EA; Buchsbaum MS
    Am J Psychiatry; 2005 Sep; 162(9):1733-5. PubMed ID: 16135634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid cortico-limbic alterations in AMPA receptor densities after administration of PCP: implications for schizophrenia.
    Zavitsanou K; Nguyen V; Newell K; Ballantyne P; Huang XF
    J Chem Neuroanat; 2008 Oct; 36(2):71-6. PubMed ID: 18640263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phasic cholinergic signaling in the hippocampus: functional homology with the neocortex?
    Gulledge AT; Kawaguchi Y
    Hippocampus; 2007; 17(5):327-32. PubMed ID: 17407133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered M(1) muscarinic acetylcholine receptor (CHRM1)-Galpha(q/11) coupling in a schizophrenia endophenotype.
    Salah-Uddin H; Scarr E; Pavey G; Harris K; Hagan JJ; Dean B; Challiss RA; Watson JM
    Neuropsychopharmacology; 2009 Aug; 34(9):2156-66. PubMed ID: 19404243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in cortical gene expression in the muscarinic M1 receptor knockout mouse: potential relevance to schizophrenia, Alzheimer's disease and cognition.
    Dean B; Scarr E
    NPJ Schizophr; 2021 Sep; 7(1):44. PubMed ID: 34521861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia.
    Glantz LA; Lewis DA
    Arch Gen Psychiatry; 2000 Jan; 57(1):65-73. PubMed ID: 10632234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distribution of kainate receptor subunit mRNAs in human hippocampus, neocortex and cerebellum, and bilateral reduction of hippocampal GluR6 and KA2 transcripts in schizophrenia.
    Porter RH; Eastwood SL; Harrison PJ
    Brain Res; 1997 Mar; 751(2):217-31. PubMed ID: 9099808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The distribution and morphology of prefrontal cortex pyramidal neurons identified using anti-neurofilament antibodies SMI32, N200 and FNP7. Normative data and a comparison in subjects with schizophrenia, bipolar disorder or major depression.
    Law AJ; Harrison PJ
    J Psychiatr Res; 2003; 37(6):487-99. PubMed ID: 14563380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Somal size of prefrontal cortical pyramidal neurons in schizophrenia: differential effects across neuronal subpopulations.
    Pierri JN; Volk CL; Auh S; Sampson A; Lewis DA
    Biol Psychiatry; 2003 Jul; 54(2):111-20. PubMed ID: 12873800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of m1/m4 muscarinic receptors in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression disorder.
    Zavitsanou K; Katsifis A; Mattner F; Huang XF
    Neuropsychopharmacology; 2004 Mar; 29(3):619-25. PubMed ID: 14694353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia.
    Garey LJ; Ong WY; Patel TS; Kanani M; Davis A; Mortimer AM; Barnes TR; Hirsch SR
    J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):446-53. PubMed ID: 9771764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease.
    Araujo DM; Lapchak PA; Robitaille Y; Gauthier S; Quirion R
    J Neurochem; 1988 Jun; 50(6):1914-23. PubMed ID: 3373218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamin E can compensate the density of M1 receptors in the hippocampus of scopolamine-treated rats.
    Sayyahi A; Jahanshahi M; Amini H; Sepehri H
    Folia Neuropathol; 2018; 56(3):215-228. PubMed ID: 30509043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibroblast growth factor 2 is necessary for the growth of glutamate projection neurons in the anterior neocortex.
    Korada S; Zheng W; Basilico C; Schwartz ML; Vaccarino FM
    J Neurosci; 2002 Feb; 22(3):863-75. PubMed ID: 11826116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuregulin-1 (NRG-1) mRNA and protein in the adult human brain.
    Law AJ; Shannon Weickert C; Hyde TM; Kleinman JE; Harrison PJ
    Neuroscience; 2004; 127(1):125-36. PubMed ID: 15219675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. M1 muscarinic receptor signaling in mouse hippocampus and cortex.
    Porter AC; Bymaster FP; DeLapp NW; Yamada M; Wess J; Hamilton SE; Nathanson NM; Felder CC
    Brain Res; 2002 Jul; 944(1-2):82-9. PubMed ID: 12106668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.